Company: NIVFW
Filing Date: 2025-08-21
Form Type: DRS
Source: 0001213900-25-079301
Chunk: 79

Company: NewGenIvf Group Ltd
Filing Date: 2025-08-21
Form: DRS
Chunk 79
---
. Conflicts of interest may
also arise in connection with the exercise of contractual remedies, such as the treatment of events of default. As a result, those related
party transactions, individually or in the aggregate, may have an adverse effect on NewGenIvf’s business and results of operations.

NewGenIvf may be subject to claims and allegations relating to intellectual property and other causes.

NewGenIvf may from time
to time receive claims that NewGenIvf infringes on the intellectual property rights of others. Moreover, NewGenIvf may be subject to
claims by third parties who maintain that NewGenIvf’s service providers’ technology infringes third-party’s
intellectual property rights. If NewGenIvf fails to successfully defend against such claim or does not prevail in such litigation,
it could be required to modify, redesign or cease operating, pay monetary amounts as damages or enter into royalty or licensing
arrangements with the valid intellectual property holders. Any royalty or licensing arrangements that NewGenIvf may seek in such
circumstances may not be available to it on commercially reasonable terms or at all. Also, if NewGenIvf acquires technology licenses
from third parties, NewGenIvf’s exposure to infringement actions may increase because NewGenIvf must rely upon these third
parties to verify the origin and ownership of such technology. This exposure to liability could result in disruptions in
NewGenIvf’s business that could materially and adversely affect NewGenIvf’s results of operations.

<div align='center'>44</div>

Some of NewGenIvf’s
employees may previously employed at other companies, including NewGenIvf’s competitors. NewGenIvf may hire additional personnel
to expand its development team and technical support team as its business grows. To the extent these employees were involved in the development
of content or technology similar to NewGenIvf’s at their former employers, NewGenIvf may become subject to claims that these employees
or NewGenIvf has appropriated these employees’ former employers’ proprietary information or intellectual properties. If NewGenIvf
fails to successfully defend such claims against itself, NewGenIvf may be exposed to liabilities which could have a material adverse effect
on its business.

NewGenIvf is currently not
a party to any material legal or administrative proceedings but may subject to legal or administrative actions for defamation, negligence,
copyright and trademark infringement, unfair competition, breach of service terms, or other purported injuries resulting from the